Product Name: | Sildenafil Citrate |
Synonyms: | 1-[[3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate (1:1) |
CAS No: | 171599-83-0 |
Chemical Formula: | C₂₈H₃₈N₆O₁₁S |
Grade: | BP/USP |
Appearance: | White to off-white crystalline powder. |
Molar Mass: | 666.7 g/mol |
Solubility: | Sparingly soluble in water |
Description
Chemignition is a leading manufacturer and exporter of Sildenafil Citrate Active Pharmaceutical Ingredients (API) worldwide. The company adheres to strict Quality Management Systems (QMS) to ensure compliance with Good Manufacturing Practices (cGMPs). This commitment to quality and regulatory standards guarantees that Chemignition produces Sildenafil Citrate of the highest quality and efficacy.
Sildenafil Citrate primarily treats erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). It works by increasing blood flow to the penis during sexual stimulation, helping achieve and maintain an erection. Additionally, Sildenafil Citrate lowers pulmonary blood pressure in patients with PAH.
During the manufacturing of Active Pharmaceutical Ingredients (API) and specialty chemicals, Chemignition employs various processes, including dissolution, charcoalization, filtration, leaching, extraction, crystallization, and purification.
The U.S. Food and Drug Administration (FDA) approved Sildenafil Citrate on March 27, 1998, for the treatment of erectile dysfunction. As the first oral treatment approved for this condition, it significantly impacted the market and expanded treatment options for men with ED. The FDA later approved its use for PAH in 2005.
Storage Condition: Pack Sildenafil Citrate in a double polybag, keep it in a tightly closed HDPE container, and store it at a temperature between 20°C and 25°C.